The Technical Analyst
Biosig Technologies Inc [BSGM]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Biosig Technologies Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-1.52% $1.300
America/New_York / 25 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 14.56 mill |
| EPS: | -3.95 |
| P/E: | -0.330 |
| Earnings Date: | May 13, 2024 |
| SharesOutstanding: | 11.20 mill |
| Avg Daily Volume: | 1.205 mill |
| RATING 2024-04-25 |
|---|
| C |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | ||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.330 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -0.330 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-0.0402 (-103.09%) $-1.340 |
| Date: 2024-04-26 |
| Expected Trading Range (DAY) |
|---|
|
$ 1.176 - 1.424 ( +/- 9.54%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-01 | Hrkac Frederick | Buy | 500 000 | Common Stock |
| 2023-12-28 | Hrkac Frederick | Buy | 900 000 | Restricted Stock Units |
| 2023-12-28 | Hrkac Frederick | Buy | 600 000 | Stock Option (Right to Buy) |
| 2023-11-30 | Sieckhaus John | Buy | 92 300 | Common Stock |
| 2023-11-30 | Fleming Gray | Buy | 131 900 | Common Stock |
| INSIDER POWER |
|---|
| 100.00 |
| Last 95 transactions |
| Buy: 6 442 688 | Sell: 40 000 |
Forecast:
16:00 - $1.290
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $1.290
Forecast 2: 16:00 - $1.290
Forecast 3: 16:00 - $1.290
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.300 (-1.52% ) |
| Volume | 0.0540 mill |
| Avg. Vol. | 1.205 mill |
| % of Avg. Vol | 4.48 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BSGM
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
BSGM
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Latest Press Releases
2024-04-04 11:35:00 - Press Release
Biosig Engages Consulting Firm For Business Model Strategies
Baipc will work to deploy a series of solutions to transform biosig's future course baipc will work to deploy a series of solutions to transform biosig's future course
2024-02-20 10:00:00 - Press Release
Biosig Announces Reduction Of Its Workforce
Westport, ct, feb. 20, 2024 (globe newswire) -- -- biosig technologies, inc. (nasdaq: bsgm) ("biosig" or the "company"), a medical technology company, today announced that it has terminated a significant number of its employees and expects to substantially reduce business operations.
2024-02-06 08:30:00 - Press Release
Biosig's Pure Ep™ Platform With New Near Field Tracking Algorithm Surpasses 100 Patient Cases
Company sees clinical adoption and usage of its novel near field tracking algorithm, proven to reduce ablation time by approximately 66%. company sees clinical adoption and usage of its novel near field tracking algorithm, proven to reduce ablation time by approximately 66%.
2024-01-31 11:15:00 - Press Release
Biosig Announces Reverse Stock Split
Common stock will begin trading on split-adjusted basis on february 2, 2024 common stock will begin trading on split-adjusted basis on february 2, 2024
2024-01-30 08:30:00 - Press Release
Biosig Announces Cost Reductions To Improve Its Financial Standing And Shifts Its Core Strategy
Westport, ct, jan. 30, 2024 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) ("biosig" or the "company"), a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced a workforce reduction, intended to reduce annual cash burn by 50%. the company is reducing its internal workforce, which is expected to be completed by january 31. the company is also shifting its business model and seeks to partner with organizations for sales distribution and clinical support of its pure ep™ platform.
Latest News
2023-08-25 11:17:06 - Zacks Investment Research
BioSig (BSGM) Grows in Arrhythmia Care With Subscription Model
BioSig's (BSGM) subscription model for PURE EP provides electrophysiologists and cardiology departments with flexibility.
2023-07-20 08:59:33 - InvestorPlace
Why Is BioSig Technologies (BSGM) Stock Up 19% Today?
BioSig Technologies (NASDAQ: BSGM ) stock is rising higher on Thursday as subsidiary BioSig AI Sciences joins Nvidia's (NASDAQ: NVDA ) Inception program. The Inception program is one that Nvidia uses to select companies with promising developments in the AI and data sciences spaces.
2023-06-29 12:54:07 - Zacks Investment Research
BioSig (BSGM) Inks New Deal to Advance AI in Electrophysiology
The foundation of BioSig's (BSGM) AI medical device platform is set to be built upon integrated healthcare datasets.
2023-02-11 11:00:00 - PennyStocks
The Benefits of Investing in Penny Stocks in the Long Term
Why investing in penny stocks in the long term could be the right choice The post The Benefits of Investing in Penny Stocks in the Long Term appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-10-06 15:05:58 - PennyStocks
4 Hot Penny Stocks To Buy For Under $1 Before Next Week
Penny stocks under $1 to watch before next week. The post 4 Hot Penny Stocks To Buy For Under $1 Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-09-08 14:18:18 - Zacks Investment Research
3 Medical Instruments Stocks With Potential to Outperform
Here we discuss ShockWave Medical (SWAV), CheckCap (CHEK) and Biosig Technologies (BSGM) that have the potential to outperform their industry going forward.
2022-09-08 09:33:25 - Benzinga
Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed higher by more than 400 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.
2022-09-01 09:21:48 - Benzinga
(BSGM), (LDI) – BioSig Technologies, Reliance Global Group And 2 Other Penny Stocks Insiders Are Aggressively Buying
U.S. stocks recorded losses for the fourth straight session on Wednesday. Investors, meanwhile, focused on some notable insider trades.
2022-07-07 08:49:45 - Proactive Investors
BioSig Technologies says Kansas City Heart Institute signs purchase agreement for its PURE EP System
BioSig Technologies Inc has announced that Kansas City Heart Institute at Overland Park Regional Medical Center in Kansas City, USA, has signed a purchase agreement to acquire its PURE EP System. Following its evaluation of BioSig's PURE EP System, Overland Park Regional Medical Center (OPRMC) has signed an agreement to purchase the technology under the terms of the company's new program.
2022-06-30 11:23:45 - Proactive Investors
BioSig Technologies gets repeat 'Outperform' tag, $4 price target from Noble Capital
BioSig Technologies Inc has earned a reiterated ‘Outperform' rating and $4 price target from analysts at Noble Capital days after pricing a public offering that generated proceeds of $2.9 million. The offering was “[a] bit unexpected, timing-wise, but supports PURE EP commercialization,” the firm wrote.